Hoth Therapeutics Inc (HOTH)
1.18
-0.01
(-0.84%)
USD |
NASDAQ |
May 08, 16:00
1.18
0.00 (0.00%)
After-Hours: 20:00
Hoth Therapeutics Cash from Investing (TTM): 0.00 for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | -0.0075M |
June 30, 2023 | 0.0025M |
March 31, 2023 | 1.187M |
December 31, 2022 | 1.162M |
September 30, 2022 | 1.152M |
June 30, 2022 | 0.5626M |
March 31, 2022 | -1.148M |
December 31, 2021 | -0.1654M |
September 30, 2021 | -0.9696M |
June 30, 2021 | 0.2811M |
Date | Value |
---|---|
March 31, 2021 | -0.8906M |
December 31, 2020 | -1.838M |
September 30, 2020 | -1.041M |
June 30, 2020 | -2.562M |
March 31, 2020 | -0.8748M |
December 31, 2019 | -0.895M |
September 30, 2019 | -0.87M |
June 30, 2019 | -0.02M |
March 31, 2019 | -0.01M |
December 31, 2018 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-2.562M
Minimum
Jun 2020
1.187M
Maximum
Mar 2023
-0.365M
Average
-0.1654M
Median
Dec 2021
Cash from Investing (TTM) Benchmarks
Perspective Therapeutics Inc | 24.37M |
Electromed Inc | -1.219M |
Xtant Medical Holdings Inc | -24.78M |
Asensus Surgical Inc | 64.51M |
Myomo Inc | -2.030M |